NCT05044819 2026-04-22
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
Jazz Pharmaceuticals
Boehringer Ingelheim
AstraZeneca
A2 Healthcare Taiwan Corporation
Immunitor LLC
Biotest Pharmaceuticals Corporation